BBC vs. WNTR

Last updated Jul 14, 2026

BBC (Virtus LifeSci Biotech Clinical Trials ETF) and WNTR (YieldMax Short MSTR Option Income Strategy ETF) are both exchange-traded funds - BBC is a Health & Biotech Equities fund tracking the LifeSci Biotechnology Clinical Trials Index, while WNTR is a Derivative Income fund actively managed by YieldMax. BBC is passively managed, while WNTR is actively managed. Over the past year, BBC returned 146.38% vs 120.64% for WNTR. At a correlation of -0.31, they often move in opposite directions. BBC charges 0.79%/yr vs 1.01%/yr for WNTR.

Performance

BBC vs. WNTR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Virtus LifeSci Biotech Clinical Trials ETF (BBC) and YieldMax Short MSTR Option Income Strategy ETF (WNTR). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, BBC achieves a 33.14% return, which is significantly higher than WNTR's 10.13% return.

BBC

• 1D: -3.43%
• 1M: 19.31%
• 6M: 30.42%
• YTD: 33.14%
• 1Y: 146.38%
• 3Y*: 29.88%
• 5Y*: 2.74%
• 10Y*: 11.19%

WNTR

• 1D: 1.92%
• 1M: 18.08%
• 6M: 14.43%
• YTD: 10.13%
• 1Y: 120.64%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

BBC vs. WNTR - Yearly Performance Comparison

	2026 (YTD)	2025
BBC Virtus LifeSci Biotech Clinical Trials ETF	33.14%	109.35%
WNTR YieldMax Short MSTR Option Income Strategy ETF	10.13%	52.78%

Correlation

The correlation between BBC and WNTR is -0.28, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.28
Correlation (All Time) Calculated using the full available price history since Mar 27, 2025	-0.31

Return for Risk

BBC vs. WNTR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BBC

BBC Risk / Return Rank: 96
BBC Sharpe Ratio Rank: 98
BBC Sortino Ratio Rank: 96
BBC Omega Ratio Rank: 94
BBC Calmar Ratio Rank: 98
BBC Martin Ratio Rank: 96

WNTR

WNTR Risk / Return Rank: 70
WNTR Sharpe Ratio Rank: 88
WNTR Sortino Ratio Rank: 67
WNTR Omega Ratio Rank: 72
WNTR Calmar Ratio Rank: 71
WNTR Martin Ratio Rank: 54

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BBC vs. WNTR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Clinical Trials ETF (BBC) and YieldMax Short MSTR Option Income Strategy ETF (WNTR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	BBC	WNTR	Difference
Sharpe ratio: Return per unit of total volatility	4.08	2.26	+1.82
Sortino ratio: Return per unit of downside risk	4.42	2.47	+1.94
Omega ratio: Gain probability vs. loss probability	1.53	1.34	+0.19
Calmar ratio: Return relative to maximum drawdown	9.75	2.84	+6.91
Martin ratio: Return relative to average drawdown	28.51	7.31	+21.20

BBC vs. WNTR - Sharpe Ratio Comparison

The current BBC Sharpe Ratio is 4.08, which is higher than the WNTR Sharpe Ratio of 2.26. The chart below compares the historical Sharpe Ratios of BBC and WNTR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

BBC vs. WNTR - Drawdown Comparison

The maximum BBC drawdown since its inception was -76.85%, which is greater than WNTR's maximum drawdown of -42.65%. Use the drawdown chart below to compare losses from any high point for BBC and WNTR.

Drawdown Indicators

	BBC	WNTR	Difference
Max Drawdown Largest peak-to-trough decline	-76.85%	-42.65%	-34.20%
Max Drawdown (1Y) Largest decline over 1 year	-15.10%	-42.65%	+27.55%
Max Drawdown (3Y) Largest decline over 3 years	-54.45%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-70.92%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-76.85%	—	—
Current Drawdown Current decline from peak	-14.54%	-10.15%	-4.39%
Average Drawdown Average peak-to-trough decline	-36.97%	-20.53%	-16.44%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.16%	16.58%	-11.42%

Volatility

BBC vs. WNTR - Volatility Comparison

The current volatility for Virtus LifeSci Biotech Clinical Trials ETF (BBC) is 10.38%, while YieldMax Short MSTR Option Income Strategy ETF (WNTR) has a volatility of 18.84%. This indicates that BBC experiences smaller price fluctuations and is considered to be less risky than WNTR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BBC	WNTR	Difference
Volatility (1M) Calculated over the trailing 1-month period	10.38%	18.84%	-8.46%
Volatility (6M) Calculated over the trailing 6-month period	26.30%	47.46%	-21.16%
Volatility (1Y) Calculated over the trailing 1-year period	36.18%	53.83%	-17.65%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	39.59%	53.56%	-13.97%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	37.70%	53.56%	-15.86%

BBC vs. WNTR - Expense Ratio Comparison

BBC has a 0.79% expense ratio, which is lower than WNTR's 1.01% expense ratio.

Dividends

BBC vs. WNTR - Dividend Comparison

BBC's dividend yield for the trailing twelve months is around 1.28%, less than WNTR's 102.14% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BBC Virtus LifeSci Biotech Clinical Trials ETF	1.28%	1.70%	1.00%	0.34%	0.00%	0.00%	0.00%	0.00%	0.00%	2.09%	0.00%	0.51%
WNTR YieldMax Short MSTR Option Income Strategy ETF	102.14%	58.56%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both BBC and WNTR in my portfolio?

BBC and WNTR have a correlation of -0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, BBC or WNTR?

WNTR has higher volatility (18.84%) compared to BBC (10.38%). In terms of maximum drawdown, BBC dropped -76.85% vs WNTR's -42.65%.

Which ETF is better, BBC or WNTR?

On 1-year performance, BBC leads with 146.38% vs 120.64% for WNTR. On fees, BBC is cheaper at 0.79% per year. On volatility, BBC has been the lower-risk option at 10.38%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, BBC or WNTR?

Over the 1-year period, BBC has performed better with a 146.38% return vs 120.64%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, BBC or WNTR?

BBC is cheaper with a 0.79% expense ratio, compared with 1.01% for WNTR.

Which ETF pays a higher dividend yield, BBC or WNTR?

WNTR has the higher dividend yield at 102.14%, compared with 1.28% for BBC.

What is the main difference between BBC and WNTR?

BBC is categorized as Health & Biotech Equities, while WNTR is Derivative Income. They also come from different issuers: Virtus Investment Partners and YieldMax. Their fees differ too: 0.79% for BBC and 1.01% for WNTR.

Which has better risk-adjusted returns?

BBC currently has the higher Sharpe Ratio (4.08 vs 2.26), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.